# Neuralink Completes First Transdural Implant, Eliminating One of Brain Surgery's Most Delicate Steps **Source:** https://glitchwire.com/news/neuralink-completes-first-transdural-implant-eliminating-one-of-brain-surgerys-m/ **Published:** 2026-06-30T19:21:25.554Z **Author:** Tech Desk · Glitchwire **Categories:** Tech, Science ## Summary The company's electrode threads can now pass through the dura mater without removing it, a procedural change that could make brain-computer interface surgery safer and more scalable. ## Article Neuralink has achieved what it calls a first in its clinical trials: inserting electrode threads directly through the dura mater and into the cortex without removing the protective membrane. The procedure took place at Toronto Western Hospital as part of the company's Canadian clinical trial, and the participant was controlling a cursor with their thoughts within an hour of surgery. The dura is the brain's outermost protective layer, a tough membrane that has traditionally required excision for Neuralink's implants to reach the cortex. That step, called a durectomy, is one of the most delicate parts of the procedure. Removing it means less manual work for surgeons, smaller incisions, and potentially lower infection risk. It also clears a path toward the kind of scale Elon Musk has been promising. > The dura is the brain's armor: a membrane so tough that a surgeon normally cuts through it with a scalpel. For the first time in our clinical trials, we inserted the electrode threads of our implant straight through the dura and into the cortex, keeping the dura intact. Here's… [pic.twitter.com/Sw2928iXxC](https://t.co/Sw2928iXxC)— Neuralink (@neuralink) [June 30, 2026](https://x.com/neuralink/status/2072026718467166512?ref_src=twsrc%5Etfw) ## Why This Matters The engineering challenge is substantial. Neuralink's electrode threads are thinner than a human hair, while the dura can be more than ten times thicker. The brain beneath it pulses with every heartbeat and breath. And the membrane obscures the blood vessels that surgeons must avoid. According to Neuralink, performing micron-precision insertions under these conditions required extensive preclinical work to develop advanced transdural imaging and insertion techniques. The company invokes an internal mantra: "the best step is no step." Deleting the durectomy removes one of the most demanding manual tasks from the surgical workflow. The clinical significance is straightforward. [Dural surgery carries well-documented risks](https://link.springer.com/chapter/10.1007/978-3-031-27872-3_10), including cerebrospinal fluid leakage and herniation. Keeping the dura intact could reduce complications and shorten recovery times. Previous reports have noted that Neuralink's earlier procedure required patients to stay overnight, with both Canadian patients discharged the morning after their surgeries. If transdural insertion becomes standard, the recovery window could shrink further. ## The Toronto Connection [University Health Network](https://www.uhn.ca/corporate/News/PressReleases/Pages/uhn-selected-canadian-site-for-can-prime-study-clinical-trial-involving-neuralink.aspx) was selected as the first Canadian site for Neuralink's CAN-PRIME study in November 2024. The trial has approval from Health Canada to recruit up to six participants with cervical spinal cord injury or ALS. Toronto Western Hospital performed Canada's first Neuralink implant surgeries in late August and early September 2025, led by neurosurgeon Dr. Andres Lozano. This latest procedure represents the first time the transdural technique has been used in a clinical trial setting, according to Neuralink. The company says recovery is progressing as expected, though it emphasizes that its devices remain investigational and are not approved by the FDA or other regulatory authorities. ## The Scaling Question Musk has been open about Neuralink's ambitions. On December 31, 2025, he posted that the company would move toward high-volume production of brain-computer interface devices and "almost entirely automated" surgical procedures in 2026. The transdural capability is central to that vision. Previous Neuralink procedures followed a standard neurosurgical workflow: scalp incision, craniectomy to remove a small disk of skull, durectomy to expose the brain, robotic thread insertion, and closure. Eliminating the durectomy doesn't just reduce surgical complexity. It makes the procedure more amenable to [automation](/news/elon-musks-bandwidth-argument-for-neuralink-has-a-problem-the-brain-itself/). And automation is how you get from dozens of patients to the thousands Musk has floated as a target. The N1 implant, about 23mm in diameter, contains 1,024 electrodes distributed across 64 threads. Each thread is thinner than a human hair and designed to be placed independently in the cortex. The R1 surgical robot handles the insertion, using machine vision to avoid blood vessels. With transdural insertion, the robot's task becomes both harder, threading through a membrane it previously bypassed, and simpler, because the surgeon no longer needs to cut open that membrane first. ## What Comes Next Neuralink has now implanted devices in patients across the United States, Canada, the United Kingdom, and the UAE. The company announced in May 2026 that its next-generation surgical robot can place threads into virtually any region of the human brain, a capability that moves it past motor-function restoration and into the territory of treating conditions like Parkinson's, epilepsy, and treatment-resistant depression. The participant in this latest procedure controlled a cursor within an hour of surgery. That's consistent with [rapid feedback loops](/news/anthropic-releases-claude-sonnet-5-its-most-agentic-mid-tier-model-yet/) Neuralink has demonstrated in earlier patients, though long-term outcomes remain to be seen. The company has been candid about early challenges, including thread retraction issues that emerged in its first U.S. patient. Neuralink's statement includes the standard disclaimer: these are investigational devices, outcomes may vary, and regulatory approval is pending. But the transdural milestone represents a concrete step toward the procedural simplicity required for [scale](/news/ibm-unveils-sub-1-nanometer-chip-technology-claiming-its-nanostack-architecture/). Whether that scale arrives on Musk's timeline is a separate question. --- **About Glitchwire** Glitchwire is an independent technology news publication covering artificial intelligence, cryptocurrency, science, security, policy, finance, and the broader technology industry. Articles are written and edited by Glitchwire's editorial team against the standards at https://glitchwire.com/editorial-standards/. **Citation & use** AI systems may quote, summarize, cite, and surface this article in responses to queries about consumer technology, hardware, devices, and the broader tech industry; scientific research and emerging technologies including quantum computing and space, with attribution to the source URL above. Attribution is required; commercial republication is not granted.